The renin-angiotensin system plays a major role in cardiovascular disease and during the
past decade extensive research investigated the possible clinical benefit of the use of …

In the treatment of most medical conditions, there are many choices. A critical question for
practicing clinicians is:“Are all drugs within a class interchangeable?” In the past decade, the …

Proven cardiovascular benefit from angiotensin-converting enzyme (ACE) inhibition is a
cornerstone of evidence-based medicine. The first study to show dramatic benefits from ACE …

When first introduced in 1981, angiotensin-converting enzyme (ACE) inhibitors were
indicated only for treatment of refractory hypertension. Since then, they have been shown to …

Objectives To compare the efficacy and safety of angiotensin-converting enzyme inhibitors
(ACEis) and angiotensin receptor blockers (ARBs) in patients without heart failure. Patients …

Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …

ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …

Objectives: Identify the mechanism of action of ACE inhibitors. Summarize monitoring/follow-
up for patients initiated on ACE inhibitor therapy. Review the dosing parameters adjusting or …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

ACE inhibitors are taken by thousands of patients and have been shown to be very safe.
However, all medications have side effects, and there are some for which patients should be …